Anne F Schott
Professor of Internal Medicine
IRB Vice Chair
Internal Medicine
Internal Medicine
1500 E. Medical Ctr Dr
Ann Arbor, MI 48109
[email protected]

Available to mentor
Anne F Schott
Clinical Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • About

    Dr. Schott is a Professor of Medicine and is the Associate Director of Clinical Research for the Rogel Cancer Center. She is an expert in the field of breast cancer, has an active breast cancer practice, and frequently gives lectures and publishes about breast cancer treatment.

    Links
    • https://www.uofmhealth.org/profile/226/anne-frances-schott-md
    Qualifications
    • Leadership Trainee
      University of Michigan, Ann Arbor, 2017
    • Fellow
      University of Michigan Medical School, Internal Medicine, 1996
    • Resident
      University of Virginia Medical Center, Internal Medicine, 1992
    • Intern
      University of Virginia Medical Center, Internal Medicine, 1990
    Center Memberships
    • Center Member
      Rogel Cancer Center
    Research Overview

    Her research is focused on the development of new treatments for breast cancer, and the testing of these treatments in clinical trials.

    Recent Publications See All Publications
    • Journal Article
      Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
      Jagsi R, Griffith KA, Harris EE, Wright JL, Recht A, Taghian AG, Lee L, Moran MS, Small W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell SN, Sharp J, Sabel M, Schott A, El-Tamer M. J Clin Oncol, 2024 Feb 1; 42 (4): 390 - 398. DOI:10.1200/JCO.23.02270
      PMID: 38060195
    • Journal Article
      Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center
      Patel MA, Shah JL, Brinley FJ, Abrahamse PH, Veenstra CM, Schott AF. Cancer Medicine, 2023 Jun 12;
    • Journal Article
      Clinically significant radiation necrosis following trastuzumab-deruxtecan and brain stereotactic radiosurgery: A case series in breast cancer patients
      Wytiaz V, Schott A, Morikawa A, Kim MM. Current Problems in Cancer Case Reports, 2023 Jun; 10: 100242 - 100242. DOI:10.1016/j.cpccr.2023.100242
    • Journal Article
      204P Phase Ib study of gedatolisib plus palbociclib and endocrine therapy in women with hormone receptor positive advanced breast cancer: Updated results in treatment naïve patients
      Rugo HS, Wesolowski R, Stringer-Reasor E, Han H, Specht J, Dees C, Kabos P, Vaishampayan UN, Wander SA, Lu J, Gogineni K, Spira A, Schott A, Abu-Khalaf M, Mutka S, Suzuki S, Gorbatchevsky I, Layman RM. ESMO Open, 2023 May; 8 (1): 101393 DOI:10.1016/j.esmoop.2023.101393
    • Journal Article
      Abstract GS1-01: Race and clinical outcomes in the RxPONDER Trial (SWOG S1007)
      Abdou Y, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SK, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Unger JM, Tripathy D, Pusztai L, Hortobagyi GN, Kalinsky K. Cancer Research, 2023 Mar 1; 83 (5_Supplement): gs1-01-gs1-01 DOI:10.1158/1538-7445.sabcs22-gs1-01
    • Proceeding / Abstract / Poster
      Abstract GS1-04: Patient-reported cognitive impairment in women participating in the RxPONDER trial (SWOG S1007) by menopausal status
      Kang I, Forschmiedt JK, Loch MM, Barlow WE, Lew DL, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Rastogi P, Schott AF, Shak S, Sharma P, Miao J, Tripathy D, Pusztai L, Hortobagyi GN, Kalinsky K, Henry NL. Cancer Research, 2023 Mar 1; 83 (5_Supplement): gs1-04-gs1-04 DOI:10.1158/1538-7445.sabcs22-gs1-04
    • Journal Article
      Abstract GS3-03: GS3-03 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study
      Schott AF, Hurvitz S, Ma C, Hamilton E, Nanda R, Zahrah G, Hunter N, Tan AR, Telli M, Mesias JA, Jeselsohn R, Munster P, Lu H, Gedrich R, Mather C, Parameswaran J, Han HS. Cancer Research, 2023 Mar 1; 83 (5_Supplement): gs3-03-gs3-03 DOI:10.1158/1538-7445.sabcs22-gs3-03
    • Proceeding / Abstract / Poster
      Abstract P6-05-06: Patient-reported anxiety and fatigue in women enrolled in the RxPONDER trial (SWOG S1007) by menopausal status
      Loch MM, Forschmiedt JK, Kang IM, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Rastogi P, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Barlow WE, Tripathy D, Pusztai L, Hortobagyi GN, Kalinsky K, Henry NL. Cancer Research, 2023 Mar 1; 83 (5_Supplement): p6-05-06-p6-05-06 DOI:10.1158/1538-7445.sabcs22-p6-05-06